ID   KNA
AC   CVCL_8885
DR   CLO; CLO_0007116
DR   CLDB; cl3035
DR   ECACC; 96020765
DR   Wikidata; Q54900245
RX   PubMed=10640177;
RX   PubMed=15541571;
RX   PubMed=22538498;
CC   Population: Caucasian.
CC   Doubling time: 3.5 days (PubMed=10640177).
CC   Discontinued: ECACC; 96020765; probable.
CC   Derived from site: In situ; Adrenal gland, medulla; UBERON=UBERON_0001236.
CC   Cell type: Chromaffin cell; CL=CL_0000166.
DI   NCIt; C3326; Adrenal gland pheochromocytoma
DI   ORDO; Orphanet_276624; Sporadic pheochromocytoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   73Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 29-06-23; Version: 17
//
RX   PubMed=10640177; DOI=10.1023/A:1006959625068;
RA   Pfragner R., Behmel A., Smith D.P., Ponder B.A.J., Wirnsberger G.H.,
RA   Rinner I., Porta S., Henn T., Niederle B.;
RT   "First continuous human pheochromocytoma cell line: KNA. Biological,
RT   cytogenetic and molecular characterization of KNA cells.";
RL   J. Neurocytol. 27:175-186(1998).
//
RX   PubMed=15541571; DOI=10.1016/j.mce.2003.02.001;
RA   Eaton M.J., Duplan H.;
RT   "Useful cell lines derived from the adrenal medulla.";
RL   Mol. Cell. Endocrinol. 228:39-52(2004).
//
RX   PubMed=22538498; DOI=10.1159/000338793;
RA   Grozinsky-Glasberg S., Shimon I., Rubinfeld H.;
RT   "The role of cell lines in the study of neuroendocrine tumors.";
RL   Neuroendocrinology 96:173-187(2012).
//